SVB WEALTH LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 57 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 6.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
SVB WEALTH LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$6,000
+20.0%
46,2620.0%0.00%
Q4 2018$5,000
-54.5%
46,2620.0%0.00%
Q3 2018$11,0000.0%46,2620.0%0.00%
Q2 2018$11,000
-35.3%
46,2620.0%0.00%
-100.0%
Q1 2018$17,0000.0%46,2620.0%0.00%0.0%
Q4 2017$17,000
-10.5%
46,2620.0%0.00%0.0%
Q3 2017$19,000
-20.8%
46,2620.0%0.00%0.0%
Q2 2017$24,000
-11.1%
46,2620.0%0.00%0.0%
Q1 2017$27,000
-6.9%
46,2620.0%0.00%0.0%
Q4 2016$29,000
-31.0%
46,2620.0%0.00%
-50.0%
Q3 2016$42,000
+68.0%
46,2620.0%0.00%
+100.0%
Q2 2016$25,000
-43.2%
46,2620.0%0.00%
-50.0%
Q1 2016$44,000
-29.0%
46,2620.0%0.00%0.0%
Q4 2015$62,000
-41.0%
46,2620.0%0.00%
-50.0%
Q3 2015$105,000
+41.9%
46,2620.0%0.00%
+100.0%
Q2 2015$74,0000.0%46,2620.0%0.00%0.0%
Q1 2015$74,000
-14.9%
46,2620.0%0.00%
-33.3%
Q4 2014$87,00046,2620.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2016
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders